Gilead Sciences Pre-Tax Income decreased by 43.0% to $2.08B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 4.2%, from $2.17B to $2.08B. Over 4 years (FY 2021 to FY 2025), Pre-Tax Income shows an upward trend with a 4.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
This provides a view of profitability that is not skewed by varying tax rates or one-time tax credits.
A company's profits before the deduction of corporate income tax. It combines operating performance with non-operating f...
Used to compare companies across different tax jurisdictions to see who generates more raw profit.
is_income_before_tax| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.82B | $3.44B | $759.00M | -$152.00M | $1.50B | $2.43B | $2.03B | $1.30B | $1.59B | $2.32B | $1.65B | -$4.49B | $2.05B | $956.00M | $2.17B | $1.65B | $2.43B | $3.64B | $2.08B |
| QoQ Change | — | +89.2% | -77.9% | -120.0% | >999% | +61.8% | -16.5% | -36.0% | +22.2% | +46.0% | -28.7% | -371.4% | +145.8% | -53.4% | +126.7% | -23.9% | +47.3% | +49.9% | -43.0% |
| YoY Change | — | — | — | — | -17.3% | -29.3% | +167.6% | +955.3% | +5.7% | -4.7% | -18.6% | -445.1% | +29.3% | -58.8% | +31.1% | +136.8% | +18.3% | +280.9% | -4.2% |
We use cookies for analytics. See our Privacy and Cookie Policy.